---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042963"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2026-09-16T21:30:31+00:00"
generated_at: "2026-09-16T21:32:28.500332+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Ernexa Therapeutics posts corporate fact sheet and investor presentation; no specifics disclosed

## Summary
- Ernexa Therapeutics (ERNA) made available a corporate fact sheet and investor presentation dated September 16, 2026, via website and SEC filing.
- No financial or operational data appears in the exhibits of this filing; specific content not provided.
- Materials made available on company website on September 17, 2026.

## SEC filing metadata
- accession: 0001493152-26-042963
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2026-09-16T21:30:31+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315226042963/0001493152-26-042963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315226042963/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042963
- JSON: https://secwatch.observer/filing/0001493152-26-042963.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042963.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.